HLA-DR7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome. [electronic resource]
Producer: 19970515Description: 16-9 p. digitalISSN:- 0931-041X
- Adolescent
- Age of Onset
- Alkylating Agents -- therapeutic use
- Anti-Inflammatory Agents -- therapeutic use
- Child
- Child, Preschool
- Chlorambucil -- therapeutic use
- Cyclophosphamide -- therapeutic use
- DNA -- analysis
- Female
- HLA-DR7 Antigen -- blood
- Humans
- Infant
- Male
- Nephrotic Syndrome -- blood
- Polymorphism, Restriction Fragment Length
- Prednisone -- therapeutic use
- Retrospective Studies
- Steroids -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.